1. Canada Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Beleave Inc.

Beleave Inc.

BLEVF
Beleave Inc.US flagOther OTC
0.00
USD
- -
- -
566.00Market Cap
Beleave Inc.
BLEVF
(Other OTC)

Recent

price

0.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
TTM
FRC
0.01
0.02
0.01
0.01
0.02
0.01
0.02
0.01
- -
- -
- -
- -
- -
- -
- -
0.01
0.01
Revenue per Share
- -
- -
- -
- -
- -
- -
-0.01
-0.01
- -
- -
- -
-0.01
-0.03
-0.06
-0.05
-0.08
-0.03
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-0.01
- -
-0.02
-0.03
-0.04
0.01
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
-0.01
-0.01
-0.01
-0.01
-0.01
-0.01
-0.05
-0.06
-0.06
-0.03
-0.03
-0.01
-0.04
-0.01
- -
-0.01
-0.01
Book Value per Share
- -
- -
- -
- -
- -
- -
- -
-0.01
-0.01
- -
- -
0.01
- -
0.02
0.04
0.02
0.01
Tangible Book Value per Share
83
84
88
100
101
101
34
34
34
73
83
88
97
151
239
409
498
Basic Weighted Avg Shares
1
1
1
1
2
1
1
- -
- -
- -
- -
- -
- -
- -
- -
2
3
Sales/Revenue/Turnover
5.4
0.68
-4.65
-14.93
-8.75
-11.24
-12.74
-63.79
- -
- -
- -
- -
- -
- -
- -
-1,000.06
-221.2
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
3
5
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
-1
-3
-9
-13
-34
-16
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
5.14
0.06
0.82
-11.81
4.54
-19.25
-25.03
-77.66
- -
- -
- -
- -
- -
- -
- -
-1,423.05
-547.57
Profit Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
8
-6
-12
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
2
3
3
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
1
- -
3
9
10
7
Total Equity
72.15
5.56
-19.11
- -
-30.81
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
-5.19
-0.07
-0.83
- -
-5.4
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Jun'20
Sep'20
Dec'20
ST Debt
9
9
9
LT Borrowings
3
2
2
LT Finance Leases
1
1
1
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
483
497
518
Market Capitalization
40
18
5

Working Capital

FRC

•

in mil. unless spec.
Jun'20
Sep'20
Dec'20
Total Current Assets
4
4
3
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
3
2
2
Total Current Liabilities
12
14
15
Payables & Accruals
3
4
5
ST Debt
9
9
9
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-499.8%
-868.12%
10.58%
Free Cash Flow
909.21%
1,266.46%
128.9%
Net Income, GAAP
201.8%
422.17%
167.24%
Sales/Revenue/Turnover
- -
- -
532.21%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
- -
- -
- -
- -
2019
- -
- -
1
1
2
2020
1
1
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
-0.02
- -
-0.01
- -
-0.05
2019
-0.03
-0.01
-0.02
- -
-0.08
2020
- -
-0.01
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2018
- -
- -
- -
- -
- -
2019
- -
- -
- -
- -
- -
2020
- -
- -
- -
- -
- -
Similar Companies
Alpa Laboratories Limited (ALPA.NS)
Akums Drugs & Pharmaceuticals Ltd. (AKUMS.NS)
The Hash Corporation (REZN.CN)
C21 Investments Inc. (CXXI.CN)
Piramal Pharma Limited (PPLPHARMA.BO)
Teva Pharmaceutical Industries Limited (TEVJF)
Business
Beleave Inc. formerly functioned as a Canadian enterprise engaged in the cannabis sector. The organization was involved in the cultivation and distribution of medical and adult-use cannabis products. Its offerings encompassed various forms, including dried flower, oils, extracts, and vape pens. Additionally, the company operated a network of medical cannabis clinics across Ontario and Quebec, branded as Medi-Green. Beleave also pursued research initiatives focused on developing pharma-grade extracts and derivatives. The company's products reached consumers through its retail channels and online storefronts. However, in June 2020, Beleave Inc. initiated proceedings for creditor protection under Canada's Companies' Creditors Arrangement Act, citing insolvency and an impending liquidity crisis, with the intent to sell its assets. The company was previously headquartered in Oakville, Canada.